Cannabigerol - 20 mg/ml solution in methanol
CAS: 25654-31-3
Ref. 3D-FC42726
5mg | 136.00 € | ||
10mg | 177.00 € | ||
25mg | 352.00 € | ||
50mg | 548.00 € | ||
100mg | 970.00 € |
Product Information
- CBG
- (E)-2-(3,7-Dimethylocta-2,6-dien-1-yl)-5-pentylbenzene-1,3-diol
- 1,3-Benzenediol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-
- 1,3-Benzenediol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-, (E)-
- 1,3-Benzenediol, 2-[(2E)-3,7-dimethyl-2,6-octadien-1-yl]-5-pentyl-
- 1,3-Benzenediol, 2-[(2E)-3,7-dimethyl-2,6-octadienyl]-5-pentyl-
- 2-((2E)-3,7-Dimethylocta-2,6-dienyl)-5-pentylbenzene-1,3-diol
- 2-[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]-5-pentyl-1,3-benzenediol
- Cannabigerol
- Resorcinol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-
- See more synonyms
- Resorcinol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-, (E)-
Cannabigerol is a non-psychotropic phytocannabinoid which has a low affinity for the CB1 and CB2 receptors but affects the endocannabinoid system by inhibiting anandamide uptake (Morales, 2017). It also acts as a potent alpha2+adrenoceptor agonist (EC50= 0.2 nM) (Cascio, 2010). In vitro, cannabigerol was shown to reduce cell loss viability and inhibit apoptosis in motor neurons as well as reducing inflammatory cytokine levels in neural cultures. In in vivo experimental animal models it was shown to antagonize the 5-HT1A receptor (Kb= 51.9 nM) (Cascio, 2010), inhibit vas deferens contractions via a2 adrenoceptor mediation as well as improve motor deficits and prevent neurotoxicity and the upregulation of proinflammatory markers on striatal neurons in mice models (Valdeolivas, 2015).
Chemical properties
Technical inquiry about: 3D-FC42726 Cannabigerol - 20 mg/ml solution in methanol
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.